Teva agrees opioid settlement with Rhode Island
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA TASE: TEVA) has introduced that it has attained an arrangement with the Legal professional Typical of Rhode Island that settles the state’s opioid-relevant promises.

Under the terms of the settlement, Teva will fork out Rhode Island $21 million over 13-many years. The Israeli pharmaceutical organization will also offer Rhode Island its lately released generic opioid overdose remedy Narcan (naloxone hydrochloride nasal spray) and a major quantity of buprenorphine naloxone (sublingual tablets), known by the brand name identify Suboxone, valued at a merged $78.5 million (wholesale acquisition value) more than 10 yrs.




Similar Content











The settlement framework is reliable with beforehand announced settlements. In February, Teva arrived at a similar settlement with Texas in which it will pay back $150 million more than 15 decades and offer Narcan worthy of ($75 million (wholesale acquisition price tag) more than 10 several years.

Teva stressed that the settlement settlement is not an admission of any liability or wrongdoing and the corporation will continue on to protect alone in court docket, in states where by we have not reached phrases of a settlement settlement.

Released by Globes, Israel small business information – en.globes.co.il – on March 22, 2022.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2022.


